AFAS
Acorn Financial Advisory Services’s Collegium Pharmaceutical COLL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Sell |
37,232
-1,427
| -4% | -$42.2K | 0.18% | 62 |
|
|
2025
Q1 | $1.15M | Buy |
38,659
+9,979
| +35% | +$298K | 0.21% | 58 |
|
|
2024
Q4 | $822K | Sell |
28,680
-1,429
| -5% | -$40.9K | 0.14% | 80 |
|
|
2024
Q3 | $1.16M | Sell |
30,109
-833
| -3% | -$32.2K | 0.21% | 55 |
|
|
2024
Q2 | $996K | Sell |
30,942
-8,338
| -21% | -$268K | 0.19% | 66 |
|
|
2024
Q1 | $1.52M | Sell |
39,280
-7,597
| -16% | -$295K | 0.29% | 44 |
|
|
2023
Q4 | $1.44M | Sell |
46,877
-1,377
| -3% | -$42.4K | 0.25% | 60 |
|
|
2023
Q3 | $1.08M | Buy |
48,254
+333
| +0.7% | +$7.44K | 0.19% | 78 |
|
|
2023
Q2 | $1.03M | Sell |
47,921
-1,826
| -4% | -$39.2K | 0.18% | 81 |
|
|
2023
Q1 | $1.19M | Sell |
49,747
-3,662
| -7% | -$87.9K | 0.23% | 64 |
|
|
2022
Q4 | $1.24M | Sell |
53,409
-3,649
| -6% | -$84.7K | 0.26% | 53 |
|
|
2022
Q3 | $914K | Sell |
57,058
-5,473
| -9% | -$87.7K | 0.22% | 69 |
|
|
2022
Q2 | $1.11M | Sell |
62,531
-2,272
| -4% | -$40.3K | 0.26% | 55 |
|
|
2022
Q1 | $1.32M | Sell |
64,803
-5,034
| -7% | -$102K | 0.26% | 65 |
|
|
2021
Q4 | $1.31M | Buy |
69,837
+1,025
| +1% | +$19.2K | 0.26% | 63 |
|
|
2021
Q3 | $1.36M | Buy |
68,812
+12,090
| +21% | +$239K | 0.42% | 63 |
|
|
2021
Q2 | $1.34M | Buy |
56,722
+993
| +2% | +$23.5K | 0.4% | 73 |
|
|
2021
Q1 | $1.32M | Buy |
55,729
+2,105
| +4% | +$49.9K | 0.48% | 59 |
|
|
2020
Q4 | $1.07M | Buy |
53,624
+14,331
| +36% | +$287K | 0.42% | 70 |
|
|
2020
Q3 | $818K | Buy |
39,293
+9,725
| +33% | +$202K | 0.43% | 67 |
|
|
2020
Q2 | $517K | Sell |
29,568
-48
| -0.2% | -$839 | 0.36% | 99 |
|
|
2020
Q1 | $484K | Sell |
29,616
-1,767
| -6% | -$28.9K | 0.48% | 73 |
|
|
2019
Q4 | $646K | Buy |
+31,383
| New | +$646K | 0.54% | 59 |
|